Phase III Study of Cyclophosphamide, Doxorubicin, and Fluorouracil (CAF) Plus Leucovorin Versus CAF for Metastatic Breast Cancer: Cancer and Leukemia Group B 9140 von PARNES, H. L, CIRRINCIONE, C, SZATROWSKI, T. P, HENDERSON, I. C, NORTON, L, AISNER, J, BERRY, D. A, ALLEN, S. L, ABRAMS, J, CHUANG, E, COOPER, M. R, PERRY, M. C, DUGGAN, D. B

Volltext

A phase I study of cabozantinib plus nivolumab (CaboNivo) in patients (pts) refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors von Apolo, A.B., Mortazavi, A., Stein, M., Pal, S.K., Davarpanah, N., Parnes, H.L., Ning, Y.M., Francis, D.C., Cordes, L.M., Berniger, M., Steinberg, S.M., Monk, P., Lancaster, T., Mayer, T., Costello, R., Bottaro, D.P., Dahut, W.L.

Volltext

Final results of a phase I study of cabozantinib (cabo) plus nivolumab (nivo) and cabonivo plus ipilimumab (Ipi) in patients (pts) with metastatic urothelial carcinoma (mUC) and ot... von Nadal, R., Mortazavi, A., Stein, M., Pal, S.K., Davarpanah, N., Parnes, H.L., Ning, Y.M., Cordes, L.M., Lin, J., Bagheri, M., Linderberg, L., Berniger, M., Steinberg, S.M., Moore, T., Lancaster, T., Aviles, M., Costello, R., Bottaro, D.P., Dahut, W.L., Apolo, A.B.

Volltext

A phase II study of cabozantinib in patients (pts) with relapsed/refractory metastatic urothelial carcinoma (mUC) von Nadal, R., Parnes, H.L., Francis, D.C., Cordes, L.M., Berninger, M., Costello, R., Folio, L., Linderberg, M., Machado, L., Steinberg, S.M., Wright, J.J., Ning, Y.M., Bottaro, D.P., Dahut, W.L., Apolo, A.B.

Volltext

Met Tumor Expression and Mutational Analysis in Bladder Cancer Patients (Pts) Receiving Cabozantinib von Apolo, A.B., Bottaro, D.P., Merino, M.J., Xi, L., Lee, Y.H., Weinberg, B.A., Wright, J.J., Dahut, W.L., Parnes, H.L., Raffeld, M.

Volltext

811PDMET TUMOR EXPRESSION AND MUTATIONAL ANALYSIS IN BLADDER CANCER PATIENTS (PTS) RECEIVING CABOZANTINIB von Apolo, A.B., Bottaro, D.P., Merino, M.J., Xi, L., Lee, Y.H., Weinberg, B.A., Wright, J.J., Dahut, W.L., Parnes, H.L., Raffeld, M.

Volltext

Intraprostatic inflammation is positively associated with serum PSA in men with PSA 4 ng [ml.sup.-1], normal DRE and negative for prostate cancer von Umbehr, M.H, Gurel, B, Murtola, T.J, Sutcliffe, S, Peskoe, S.B, Tangen, C.M, Goodman, P.J, Thompson, I.M, Lippman, S.M, Lucia, M.S, Parnes, H.L, Drake, C.G, Nelson, W.G, De Marzo, A.M, Platz, E.A

Volltext